New England Psychologist - nepsy.com Banner Ad
An Independent Voice for the State's Psychologist
Psy Jobs CE Listings Archives Contact
HomeColumnsBook ReviewsHospital DirectoryAdvertisingClassifiedsAbout Us

Study says therapy is better than pills for insomnia
(December 2004 Issue)

By Nan Shnitzler

As little as two hours of cognitive behavioral therapy (CBT) can do more to relieve chronic sleep-onset insomnia than the most widely prescribed sleeping pill, according to results of a federally funded study published in the Sept. 27 issue of the Archives of Internal Medicine.

"Sleeping pills are the most frequent treatment for insomnia, yet CBT techniques clearly were more successful in helping the majority of study participants become normal sleepers," says study leader Gregg Jacobs, Ph.D., of the Sleep Disorders Center at Beth Israel Deaconess Medical Center in Boston, Mass.

The study at Harvard Medical School, where Jacobs is an assistant professor of psychiatry, evaluated the separate and combined effects of CBT and medication in 63 participants aged 25 to 64. Participants divided in four random groups received Ambien (zolpidem), four half-hour sessions of CBT, a combination, or placebo. Participants kept sleep diaries to record such measures as sleep-onset latency, sleep efficiency (time slept divided by time allotted for sleep), and total sleep time. A Nightcap-brand sleep monitor recorded variables at baseline and at the end of the treatment period.

Results showed no advantage of combined treatment over CBT alone. At the four-week mid-treatment point, the CBT and combined groups showed 44 percent reduction in sleep-onset latency, compared with 29 percent for the Ambien group and 10 percent for the placebo group. At six weeks, Ambien subjects tapered medication to discontinuation. At eight weeks, CBT and combination treatment showed a further reduction in sleep-onset latency to 52 percent.

However, measured against the sleep-onset latency norm of 30 minutes and sleep efficiency of 85 percent, CBT subjects did better than the combined group after eight weeks, 57 versus 46 percent and 57 versus 54 percent respectively. By the end of the eight-week period, insomnia experienced by the Ambien group returned to baseline levels, similar to the placebo group.

An earlier study, also funded by the National Institutes of Health, published March 1999 in the Journal of the American Medical Association by Charles Morin, Ph.D. tested elderly participants with sleep-maintenance insomnia and found that a combination of sleeping pills and therapy worked best short term, but therapy alone provided longer-lasting benefits.

Young and middle-aged adults was a significant population that hadn't been tested before," Jacobs says.

Based on these results and meta-analyses of 60 peer-reviewed empirical studies, Jacobs is satisfied that behavioral therapy to help change sleep habits should be the first line treatment for the one-third of the nation's adults that complain of insomnia and figures 75 percent of patients would derive significant clinical benefit.

"This was the final study that was needed," Jacobs says. "Now we have two independent, federally funded studies whose outcome data show therapy is more effective than pills."

Jacobs' next step is to provide access to CBT as easily as doctors prescribe sleeping pills. In addition to books, such as Jacobs' own "Say Goodnight to Insomnia" (Holt 1999), the Internet is the obvious choice.

"We know we can take CBT and turn it into a six-week structured interactive program to use long term. That's our goal," Jacobs says.

Carl Hunt, M.D., director of the NIH National Center on Sleep Disorders Research thinks Jacobs study "helps reinforce the important role CBT has in the treatment of insomnia."

However, Hunt says, "This study doesn't address difficulty staying asleep, which is more common than difficulty getting to sleep, with increased frequency and severity as we get older. It should not be assumed the results would be the same."